allergic rhinitis(AR)
Conditions
Interventions
Control Group:Bi Min Fang decoction
Intervention Group:Bi Min Fang granules
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Subjects who meet the Chinese and Western diagnostic criteria for AR, those with Chinese medicine syndrome differentiation of Lung and Sleen deficiency, and those who meet the criteria for persistent allergic rhinitis (symptom onset = 4 days/week, and = 4 consecutive weeks). ? 18-65 years old, no gender limited. ? Subjects need informed consent, voluntarily accept the treatment according to the research allocation plan, basically can adhere to the treatment and follow-up plan, and have good compliance. ? Subjects are able to complete relevant records such as case report form as required.
Exclusion criteria
Exclusion criteria: ? Patients who do not accept the contents of this trial. ? Patients combined with severe cardiovascular and cerebrovascular diseases, immunodeficiency, mental disorders or abnormal liver and kidney function and malignant tumors. ? For women who are pregnant or breastfeeding, if pregnancy is found during the trentment period, the test will be suspended. ? Patients who are easily lost to follow-up due to frequent changes in the work environment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total nasal symptom score, TNSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| the standardize dversion of the Rhinoconjunctivitis Quality of Life Questionnaire,RQLQ(S);eye symptom score;Rhinitis Control Assessment Test,RCAT;Use of anti-allergy medication scores; | — |
Countries
China
Contacts
Public ContactLuo Qiulan
Outcome results
None listed